You are here

Elder

Medicare Recipients Could Find Drug Cost Relief in Health Bill

Medicare -- New York Times - 12 min 22 sec ago
Starting in 2025, Medicare recipients with prescription drug coverage will not have to pay more than $2,000 annually for medications, a significant savings for some.
Categories: Elder, Medicare

Overlooked Provisions

Medicare -- New York Times - Tue, 08/09/2022 - 6:37am
Climate has received most of the attention. But the Senate bill brings big changes to health care, too.
Categories: Elder, Medicare

The vote was a major victory for

Medicare -- New York Times - Sun, 08/07/2022 - 3:27pm
The vote was a major victory for President Biden and Democrats, who are battling to maintain their slim House and Senate majorities in November’s midterm congressional elections.
Categories: Elder, Medicare

Here’s How Democrats’ Big Domestic Agenda Bill Has Shrunk

Medicare -- New York Times - Sun, 08/07/2022 - 2:40pm
The legislation was a major victory for President Biden and Democrats, but a shadow of the transformative, multitrillion-dollar plan they proposed last year.
Categories: Elder, Medicare

Climate and Tax Bill Clears Test Vote in Senate

Medicare -- New York Times - Sat, 08/06/2022 - 7:46pm
Democrats united behind the plan and advanced it over unanimous Republican opposition, signaling that they had finally coalesced behind a bill that could become law within days.
Categories: Elder, Medicare

Democrats’ Long-Sought Plan for Lowering Drug Costs Is at Hand

Medicare -- New York Times - Fri, 08/05/2022 - 2:29pm
Empowering Medicare to negotiate prices directly with drug makers has been a Democratic goal for 30 years, one the pharmaceutical industry has fought ferociously.
Categories: Elder, Medicare

Biden’s Climate-Change Bill Won’t Tax the Middle Class

Medicare -- New York Times - Thu, 08/04/2022 - 7:40pm
No, Biden’s climate-change bill won’t tax the middle class.
Categories: Elder, Medicare

Democrats’ Plan to Fight Inflation May Lower Costs Over Time

Medicare -- New York Times - Thu, 07/28/2022 - 5:59pm
A package of tax increases, lower drug prices and other provisions aimed at reducing the federal budget deficit could alleviate rapid price gains.
Categories: Elder, Medicare

Biden Rule Would Strengthen Health Protections for Gay and Transgender People

Medicare -- New York Times - Mon, 07/25/2022 - 10:18pm
The proposed rule would prohibit discrimination on the basis of sexual orientation and gender identity by health care providers that receive federal funding.
Categories: Elder, Medicare

Build Back Better Is a Health Care Bill Now

Medicare -- New York Times - Fri, 07/15/2022 - 3:49pm
Only two provisions in a once-sprawling social spending package have survived; they would lower prescription drug prices in Medicare and insurance premiums for millions of Americans.
Categories: Elder, Medicare

Democrats Propose Raising Taxes on Some High Earners to Bolster Medicare

Medicare -- New York Times - Thu, 07/07/2022 - 7:27pm
The draft plan, which is expected to be unveiled in the coming days, is part of talks over how to salvage pieces of President Biden’s domestic agenda.
Categories: Elder, Medicare

Out-of-Pocket Costs Put Americans into Medical Debt

Medicare -- New York Times - Thu, 07/07/2022 - 5:00am
Cost-sharing is not working as intended.
Categories: Elder, Medicare

Revising payment to Medicare Advantage plans to reflect the rapid growth in enrollment

Brookings Institute -- Medicare - Wed, 06/22/2022 - 4:09pm

In recent years, Medicare Advantage (MA)—private health plans that beneficiaries can enroll in as an alternative to traditional Medicare—has grown rapidly.  MA enrollment is projected to represent the majority of Medicare beneficiaries enrolled in both Part A and Part B by 2023. But this rapid growth has come with consequences. Basing payment on the experience of those who remain in traditional Medicare has proven challenging to pursue in a fiscally responsible manner. The consistent overpayment of MA plans over many years weighs increasingly on the Medicare trust funds and the federal budget.

On Friday, July 15, the USC-Brookings Schaeffer Initiative for Health Policy will host a conversation on the implications of the rapid growth in MA. Erin Trish, co-director of the USC Schaeffer Center for Health Policy and Economics, will present data on the rapid and pervasive increase in MA penetration. Dr. Meena Seshamani, Centers for Medicare and Medicaid Services (CMS) deputy administrator and director of the Center for Medicare, will then outline how MA can support the CMS vision for Medicare to advance health and equity, expand access, drive high-quality, person-centered care, and promote affordability and sustainability in the Medicare program.

The webcast will conclude with a panel discussion including Matthew Fiedler (The Brookings Institution), Gail Wilensky (Project HOPE), and Clive Fields (VillageMD), moderated by Paul Ginsburg (USC Schaeffer Center for Health Policy and Economics).

Viewers can follow along with the conversation on Twitter using the hashtag #MedicareAdvantageGrowth or via email at events@brookings.edu.

      
Categories: Elder

Living with COVID-19 will not be easy for many Americans suffering from long COVID-19, particularly those from diverse communities

Brookings Institute -- Medicare - Tue, 06/21/2022 - 8:20am

By Gabriel R. Sanchez, Keon L. Gilbert, Camille Busette

Introduction

In his State of the Union address earlier this year, President Joe Biden spoke of a “new moment” where the coronavirus will be more manageable and the need for masks less frequent. States have moved toward this transition as positive cases, hospitalization, and deaths began to drop. In the first week of March, governors in Mississippi, TexasAlabama, Arizona, West Virginia and Connecticut announced significant loosening of statewide pandemic restrictions like mask mandates and indoor capacity limits. These states joined several others in loosening statewide coronavirus restrictions much earlier in the year.

As we transition toward directly battling COVID-19 to the next phase in the process, we must note that “living with the virus” means something much different for those struggling with the symptoms of long COVID-19. Long COVID-19 is associated with chronic symptoms like fatigue, cognitive problems, and respiratory challenges that can linger for months after the initial coronavirus infection has passed. Long-haulers, or people who experience prolonged symptoms more than three or four weeks after infection could need several months to recover.

It is important to recognize that experiencing longer-term challenges with COVID is rather pervasive and affects not only those with severe cases, but those with relatively mild symptoms as well as Americans who are generally healthy, not just those with underlying conditions. In fact, our colleagues here at Brookings have estimated that 31 million working-age Americans—more than one in seven—may have experienced, or be experiencing, lingering COVID-19 symptoms.

The persistence of these symptoms and their ability to limit major life activities creates new considerations for immediate and long-term policy solutions. The COVID-19 pandemic increases the need to protect vulnerable communities based on current knowledge and predictions of the extension of disparate health conditions.

Similar to all other health outcomes associated with the pandemic, there are significant racial inequalities associated with long COVID-19 as vast inequalities in underlying conditions make the severity of longer-term cases more pronounced for racial and ethnic minorities. This blog post summarizes a few considerations about the racial differences among COVID-19 patients with longer-term symptoms and identifies policy solutions to help address these challenges.

Long Covid-19 will exacerbate existing racial and ethnic health inequalities

The glaring racial inequalities in COVID-19 outcomes have been well documented by Brookings and a wide range of other scholars and think tanks. It is clear that Native Americans, African Americans, and Latinos have all experienced higher rates of coronavirus infection, hospitalization and casualties throughout the pandemic.

However, our knowledge of how race impacts long-term challenges with COVID-19 is unfortunately pretty limited. A key report focused on the State of Black America and COVID-19 has identified that Black Americans have not been sufficiently included in long COVID-19 trials, treatment programs and registries. There is unfortunately limited research on other racial and ethnic minorities as well.

Challenges Facing Racial and Ethnic Minorities Struggling with Long COVID-19

It has now become clear that access to a primary care physician and adequate health care coverage as well as appropriate disability coverage will be crucial to the ways in which Americans navigate long COVID-19.

First, primary care doctors will be key to patients with long COVID-19, as many patients require comprehensive assessment to exclude serious complications that might be associated with their symptoms. A primary care clinician who knows the patient and his or her life circumstances is in an optimal position to coordinate and personalize the recovery plan and understand the barriers the patient may face along the way. Ideally patients with difficult cases would have access to holistic clinical intervention and follow‐up.

Unfortunately, there is a significant gap in access to a primary care physicians for Americans from diverse backgrounds. The African American Research Collaborative/Commonwealth Fund American COVID-19 Vaccine Poll is an extensive, diverse national survey with measures of access to primary care physician. According to the survey, 82% of white Americans reporting having a primary care doctor while only 74% of Black, 69% of Latino, and 72% of Native Americans have access to a doctor they see regularly for care.

Second, people with long COVID-19 will need adequate health coverage to manage both the financial and health components of care management. Unfortunately, racial inequalities in access to health insurance are vast, particularly for Latinos. This is a direct consequence of the several jobs held by people of color lacking sufficient healthcare benefits. Additionally, states in which Medicaid has not been expanded complicate the way in which people of color are able to manage long COVID-19.

It is important to note that long COVID-19, particularly in vulnerable groups, may be complicated by other long‐term conditions, notably diabetes, hypertension, ischemic heart disease, and chronic mental health conditions.[1] Racial and ethnic minorities are more likely to experience all of these conditions which strongly suggests that we should anticipate more complex and challenging cases for all non-white groups.

One of the other health issues associated with long-haulers is insomnia, a condition that can last months and possibly longer among Americans with long-term challenges due to COVID-19. Like most chronic health conditions, challenges with insomnia are greater among racial and ethnic minorities already, particularly for those who have high levels of perceived discrimination. Given the correlation between lack of quality sleep and a wide range of other health conditions, this may generate even greater racial inequalities in health outcomes down the line. The challenges with sleeping are likely to be exasperated by a host of underlying forces that impact sleep, including sub-par housing conditions.

The long-term effects of COVID-19 have not been realized. Our health systems and structures and the policies that regulate them will need major overhauling to be flexible enough to manage the impending social and health implications of long COVID-19. In closing, while we all enjoy the ability to feel more comfortable with expanded social interaction, and the ability to not have to wear our masks as often when we leave our homes, we must recognize that those struggling with the symptoms of long COVID-19 are far from being able to return to normalcy.

Finally, people suffering from the persistence of symptoms are eligible for disability services according to the Department of Health and Human Services. The physical impairment due to long COVID-19 can affect walking, standing, speaking, breathing, and many other physical functions that may limit one’s role in their ability to manage daily activities with their families, and in their current jobs. Because long COVID-19 can be experienced by youth and young adults, there is additional guidance on how primary, secondary, and post-secondary schools should evaluate, assess, and make academic adjustments for those in school and higher education settings.

In this post we identify the gaping racial inequalities not only associated with long COVID-19 cases, but in the resources needed to properly manage a lingering case. In future posts we will summarize the policy solutions needed to help address the challenges raised in this blog, as well as the economic consequences associated with long COVID-19 for communities of color who are already being squeezed by inflation and a slower recovery from the economic downturn.

[1] See for example: https://pubmed.ncbi.nlm.nih.gov/32419765/

      
Categories: Elder

In Older Americans, Rising Debt May Adversely Affect Health

Medicare -- New York Times - Sun, 06/05/2022 - 5:00am
Research shows that debt has risen among older people, and those who owe are more likely to have multiple diagnosed illnesses.
Categories: Elder, Medicare

The Doctor Prescribed an Obesity Drug. Her Insurer Called It ‘Vanity.’

Medicare -- New York Times - Wed, 06/01/2022 - 7:05am
Many insurance companies refuse to cover new weight loss drugs that their doctors deem medically necessary.
Categories: Elder, Medicare

Help With Medicare Costs: What You Need to Know

Medicare -- New York Times - Fri, 05/20/2022 - 12:43pm
Low-income Americans on Medicare can get assistance paying their premiums and other expenses. Several states have allowed more people to qualify.
Categories: Elder, Medicare

Biogen C.E.O. to Step Down Following Launch of Alzheimer’s Drug, Aduhelm

Medicare -- New York Times - Tue, 05/03/2022 - 11:49am
The drug company will effectively give up on marketing Aduhelm, which comes with unproven benefit and serious safety risks.
Categories: Elder, Medicare

Weekly Health Quiz: Hepatitis Symptoms, Migraine Triggers and Medicare

Medicare -- New York Times - Thu, 04/28/2022 - 11:46am
Test your knowledge of this week’s health news.
Categories: Elder, Medicare
Subscribe to Mass Legal Services aggregator - Elder